OC LIFe: Early-Stage Innovator Venture Funding

OC LIFe aims to connect industry with entrepreneurs and strengthen the life sciences and medical technology communities.

Join us for an informative panel discussion on securing venture funding for university innovators in today's economic climate. Bringing together investors, university tech translation/commercialization experts, and founders, this event will explore innovative approaches to funding ventures launched from university research or lab. Gain valuable insights and network with leaders in academia and entrepreneurship.

Create Connections that Could Last a Lifetime

The Orange County Lifesciences Innovators Forum (OC LIFe) is a monthly marquee event series focused on creating a collaborative environment that fosters connections between innovators in the life sciences and medtech industry.


The Park Club - The Monet Restaurant

650 Town Center Dr. Costa Mesa, CA 92626

Guest valet parking is available for $12, and there is ample public parking in the Center Tower Parking Garage. Complimentary valet parking to Park Club Members.

Event Schedule

5:00 PM Registration and Networking

5:45 PM Buffet Dinner

6:30 PM Panel Presentations and Discussion

7:30 PM Networking


$45 Early Bird (Non-ULP Member) - Ends May 5 at 11:59 PM PST

$75 General Admission (Non-ULP Member)

$35 ULP Members - ULP Members can find their promo code on the Community Portal.

This event is tailored for individuals in the life sciences field, including founders, executives, investors, and ULP partners.


Event Speaker

Biren Mehta-2

Biren Mehta

Vice President Venture Investments
Johnson & Johnson

Based in Irvine, California, Biren Mehta is the Vice President, Venture Investments – MedTech, where he initiates and manages equity investments to drive business innovation and deliver new and sustainable business for the MedTech sector. He is responsible for existing and new MedTech investments on the West Coast, ensuring targeted strategic options are shaped for success. Biren plays a critical role in building and maintaining networks in the venture capital community, entrepreneurs, startups, incubators and accelerators and other venture organizations that fit the strategic interests of the MedTech sector, sourcing new opportunities for the sector and positioning JJDC as the partner of choice.

Casie Kelly

Casie Kelly

Director, Research Translation
University of California, Irvine

As the Director of the Research Translation Group in Beall Applied Innovation at UC Irvine, Cassie leads a team of experienced licensing and business development professionals to effectively move the knowledge and discoveries from the university labs to the marketplace to benefit the public.

Scott Josyln

Scott Joslyn

Chief Innovation Officer, UCI Health System
SVP, UCI Health and UCI Health Ventures

Scott Joslyn is the Chief Innovation Officer and a senior vice president for UCI Health.

Reporting to the CEO, he is responsible for Innovation and UCI Health Ventures. In his capacity as innovation leader, Joslyn is involved with helping the organization to creatively solve organizational challenges and pursue new opportunities that advance and differentiate the organization.

Joslyn oversees UCI Health Ventures, a $50M capital investment fund in partnership with UCInvestments. The fund invests in young companies focused on healthcare information technology and healthcare services, as well as medical devices and biologics.

He was formerly both the Chief Information Officer and the Chief Innovation Officer for UCHealth, a dual position he held for four years before focusing exclusively on his current role. Prior to that, he was the Senior Vice President and CIO of MemorialCare.

Joslyn holds a Doctor of Pharmacy Degree from the University of the Pacific, and a Master of Business Administration from UCLA. He has taught health care information technology at California State University, Long Beach, and the University of Southern California. He is an active member of multiple industry organizations.

Stephen Laffoon

Stephen Laffoon

Penderia Technologies

Stephen is Chief Executive Officer of Penderia Technologies, a University of Oregon based startup to commercialize sensor technology for orthopedic surgical procedures. A mechanical engineer from Georgia Tech, Stephen's niche has been to connect with technologies from academia and to scale them to commercial success. Stephen was involved with two successful university based medical startups and has a background in product development, manufacturing, operations, and regulatory.

Prior to Penderia, Stephen was co-founder and Director of Engineering for Vertera Spine, who commercialized the first clinical application of porous PEEK in spinal fusion procedures and was acquired by NuVasive in 2017. Stephen remained with NuVasive until 2023, growing the porous PEEK technology within the NuVasive interbody implant portfolio. Stephen also developed a line of shape-memory PEEK orthopedic soft-tissue anchors at MedShape, Inc and designed custom manufacturing processes at CR Bard.

Event Partners


Our tagline, HR that Makes a Difference™, defines what we do. It emphasizes that human resources is a key driver of growth and contributes to a business’s bottom line. This is what sets Insperity apart.

Insperity has a long history of improving the success equation of small and midsize businesses across the country – because when businesses succeed, communities prosper.

And in today’s changing business environment, it’s our privilege to take care of an organization’s most valuable asset: its people.

NexCore Group Logo

NexCore Group is a national healthcare real estate investment and development company that focuses on acquiring, developing, owning and managing healthcare facilities including medical office buildings, wellness facilities, ambulatory surgery centers, single and multi-specialty physician buildings, life sciences facilities, seniors housing communities and transitional rehabilitation centers. NexCore has completed $4.7 billion in healthcare real estate transactions throughout 29 states, developed and acquired over 14.3 million square feet of healthcare properties across the country and currently manages over $2.9 billion of healthcare facilities spanning 7.3 million square feet. The company has been recognized repeatedly as one of the Top Healthcare Real Estate Developers in the U.S. by Modern Healthcare and HREI.


HATCHspaces ®, LLC is a Los Angeles-based real estate development platform focused on simplifying the process of scientific innovation by creating purpose-built life sciences facilities for companies emerging from academic and incubator networks. With properties in various regional submarkets, HATCHspaces’® mission is to deliver the life science community state-of-the-art lab facilities at varying scales, allowing regions to retain early-stage bioscience and biotechnology start-ups emerging from research environments.

Event Details

Community Event

Wednesday, May 22, 2024

05:00 PM - 08:00 PM

Register Now

Upcoming Event

June 11, 2024
12:00 PM - 01:00 PM

Marketing in MedTech

Register Now

Apply for residency today

Do you have a great company in the bioscience or medtech industry? Do you need wet-lab and/or fabrication space to develop and test your product?


Other Events

June 11, 2024
12:00 PM - 01:00 PM

Marketing in MedTech

Register Now
June 12, 2024
09:00 AM - 10:00 AM

SBIR/STTR Series 4/4: Commercialization Plans

Register Now
June 12, 2024
03:30 PM - 05:30 PM

Strategic Development and Regulatory Insights from Allergan Aesthetics

Register Now